Cargando…
Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588791/ https://www.ncbi.nlm.nih.gov/pubmed/33127564 http://dx.doi.org/10.1016/j.clim.2020.108618 |
| _version_ | 1783600436558692352 |
|---|---|
| author | de Miranda Santos, Isabel Kinney Ferreira de Barros Cardoso, Cristina Ribeiro |
| author_facet | de Miranda Santos, Isabel Kinney Ferreira de Barros Cardoso, Cristina Ribeiro |
| author_sort | de Miranda Santos, Isabel Kinney Ferreira |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7588791 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75887912020-10-27 Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. de Miranda Santos, Isabel Kinney Ferreira de Barros Cardoso, Cristina Ribeiro Clin Immunol Letter to the Editor Elsevier Inc. 2021-01 2020-10-27 /pmc/articles/PMC7588791/ /pubmed/33127564 http://dx.doi.org/10.1016/j.clim.2020.108618 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor de Miranda Santos, Isabel Kinney Ferreira de Barros Cardoso, Cristina Ribeiro Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. |
| title | Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. |
| title_full | Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. |
| title_fullStr | Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. |
| title_full_unstemmed | Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. |
| title_short | Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. |
| title_sort | commentary on “complement c3 vs c5 inhibition in severe covid-19: early clinical findings reveal differential biological efficacy” by d.c. mastellos et al. |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588791/ https://www.ncbi.nlm.nih.gov/pubmed/33127564 http://dx.doi.org/10.1016/j.clim.2020.108618 |
| work_keys_str_mv | AT demirandasantosisabelkinneyferreira commentaryoncomplementc3vsc5inhibitioninseverecovid19earlyclinicalfindingsrevealdifferentialbiologicalefficacybydcmastellosetal AT debarroscardosocristinaribeiro commentaryoncomplementc3vsc5inhibitioninseverecovid19earlyclinicalfindingsrevealdifferentialbiologicalefficacybydcmastellosetal |